Frequently Asked Questions
In 2022, the host cell contamination testing market was estimated to be worth USD 0.25 billion.
Between 2023 and 2030, the Host Cell Contaminant Testing market is anticipated to expand at a CAGR of 5.20%, reaching USD 0.35 billion in 2030.
Microbial is the leading segment by type.
PCR is the leading segment by test.
During the forecast period, the Pharmaceutical & Biotechnology Industries segment is expected to register the greatest CAGR.
North America is boosting the growth of the Host Cell Contaminant Testing market.
The top players include Cisbio Bioassays, Cygnus Technologies, Bio-Rad Laboratories, Inc., and Enzo Life Sciences Inc., Other major players include Thermo Fisher Scientific, ProteinSimple, and Bio-Techne.
Growing use of biopharmaceutical products and increased R&D initiatives are the main factors driving market growth.
High testing costs and complicated testing procedures limit market growth.
The primary market opportunity is the increased prevalence of chronic diseases like cancer and the growing need for customized therapies.